Stock Updates

Today’s Top Gainers in the Market BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) from Healthcare

Today’s top gainers include the company BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) which is in the industry Biotechnology, gaining 6.23% today. In the last week its performance is -0.49%, and 6.41% for the past quarter. Currently, BioMarin Pharmaceutical Inc., BMRN has a target price of 119.29, so today’s gain of 6.23% is a significant step towards its target price. The GAP today is therefore 4.00%.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), has a market cap of 15971.3, and is based in USA. Insider ownership is at 0.60%, and institutional ownership is 99.20%.

At the current price of 97.72, it has a dividend yield of *TBA, and its target price is 119.29. This is with a profit margin of -54.50%, and total debt/equity of 0.35. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has a P/E of *TBA, as well as a forward P/E of *TBA.

With a current EPS of -3.27, and a forecasted EPS growth for next year at 73.00%,BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has had a EPS growth for the past five years at -21.30%. For the next five years EPS growth is projected to be 25.00%.

Performance for the year is -32.21%. Since its IPO date on 7/26/1999, the total performance to date is -12.19%.

Volume today for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), is 2767482, while its average volume is 1820.85. Whilst the total gain today was 6.23%, it did have a day high of -4.65%.

Volatility for this week has been at 2.36%, and 3.00% for the month. The 52-week low for BioMarin Pharmaceutical Inc., BMRN has been 57.31%, while the 52-week-high has reached -28.88%.

Looking at its return of investments, which is -4.20%, and its return on assets is -15.10%. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has an operating margin of -65.20%. With a sales growth of -40.10% quarter over quarter. Bearing in mind that BioMarin Pharmaceutical Inc., BMRN is in the sector Healthcare, its long-term debt/equity is 0.34, and has a current ratio of 3 and 2.1 for quick ratio.

So what is the value of BioMarin Pharmaceutical Inc.? Well its PEG is *TBA, and the P/S is 16.4, along with a P/B of 7.8. Meanwhile it has a p/cash of 31.73.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment